Sorfequiline, previously known as TBAJ-876, was evaluated in combination with pretomanid and linezolid in a randomized, controlled trial in people with drug-sensitive TB COPENHAGEN (November 19, 2025) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback